| Literature DB >> 32524227 |
K N Schneider1, C L Correa-Martínez2, G Gosheger3, C Rickert3, D Schorn3, A Mellmann2, V Schwierzeck2, S Kampmeier2.
Abstract
BACKGROUND: With the novel coronavirus-induced disease (COVID-19), there is the fear of nosocomial infections and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmissions to healthcare workers (HCW). We report the case of a 64-year-old male patient who underwent explantation of a shoulder prosthesis due to a periprosthetic infection. He was tested SARS-CoV-2 positive 7 days after admission to the orthopaedic department following strict infection control measures, routinely including screening all patients for multi-drug-resistant organism (MDRO) colonization upon admission. Aim of our study is to report on the spreading potential of SARS-CoV-2 in a healthcare setting if standard contact precautions and infection control measures have been established.Entities:
Keywords: COVID-19; Infection; MDRO; Nosocomial; Orthopaedics; SARS-CoV-2
Mesh:
Year: 2020 PMID: 32524227 PMCID: PMC7283422 DOI: 10.1007/s00402-020-03516-1
Source DB: PubMed Journal: Arch Orthop Trauma Surg ISSN: 0936-8051 Impact factor: 3.067
Fig. 1Hygienic measures to prevent the spread of MDRO include protective isolation in a single bedroom as well as compulsory facemask, gloves and protective gown for HCW
Fig. 2Radiographic examination of the right shoulder joint (a.p. view) prior revision surgery due to periprosthetic infection
Fig. 3Radiographic examination of the right shoulder joint (Y-view), following the explantation of the hemi prosthesis and implantation of an antibiotic-impregnated bone cement spacer
Fig. 4Floor plan with the single bedroom (see red arrow, 1) where the patient stayed during protective isolation and the single bedroom on the IMC unit (see red arrow, 2)
Fig. 5Chest computed tomography of the SARS-CoV-2-positive 64-year-old male patient with right-sided multilobe involvement and ground-glass opacity and left-sided pleural effusion
Classification of contact persons according to RKI guidelines as of April 10, 2020 [10]
| Category I | Category II | Category III |
|---|---|---|
Cumulative face-to-face time of 15 min Direct contact to body fluids Exposed to aerosols and respiratory droplets (≤ 2 m) without use of protective gear | Cumulative face-to-face time of less than 15 min Exposed to aerosols and respiratory droplets (> 2 m) without use of protective gear | Exposed (≤ 2 m) with use of protective gear Exposed (> 2 m) without any direct contact to body fluids, aerosols and respiratory droplets |